Susquehanna Fundamental Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Other funds holding HZNP
N
ACA
PC
Susquehanna Fundamental Investments's HZNP Position: Q1 2022 in Review
Susquehanna Fundamental Investments opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2022: 80,526 shares worth $8.47M. The stake represents 0.17% of the portfolio and ranks #160 among its holdings. This is a return to the name: Susquehanna Fundamental Investments previously reported a position in HZNP as recently as Q3 2021.
Susquehanna Fundamental Investments first reported a position in HZNP in Q4 2020 and has held it in 5 quarters since. 620 funds tracked by Wall St. Rank hold HZNP as of Q1 2022.
- Susquehanna Fundamental Investments held 80,526 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $8.47M as of Q1 2022.
- Horizon Therapeutics Public Limited Company Ordinary Shares was a new Susquehanna Fundamental Investments position in Q1 2022.
- Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.17% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #160 holding.
- Susquehanna Fundamental Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and has held it in 5 quarters since.
- 620 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2022.
Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.